DataMeds AI (MEDS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.63, -7.72% vs the prior close of $2.85.
- Volume 286.40K shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
MEDS slides 7.7% to $2.63, a 1-month low, 4 down days in a row. Closed at $2.63, -7.72% vs the prior close of $2.85. Day range $2.62–$2.86, opened at $2.80.
MEDS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MEDS slides 7.7% to $2.63, a 1-month low, 4 down days in a row
- Closed at $2.63, -7.72% vs the prior close of $2.85. Day range $2.62–$2.86, opened at $2.80.
- Volume was 286.40K shares, 0.0x its 50-day average of 8.17M — lighter than usual.
- Price is +14.1% vs its 50-day average ($2.30) and -61.2% vs its 200-day average ($6.78).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 96.4% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — MEDS ends flat (+0.0%) to $2.85, 3 down days in a row
- Closed at $2.85, +0.00% vs the prior close of $2.85. Day range $2.65–$2.88, opened at $2.71.
- Volume was 248.70K shares, 0.0x its 50-day average of 8.18M — lighter than usual.
- Price is +23.7% vs its 50-day average ($2.30) and -58.5% vs its 200-day average ($6.86).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 96.1% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — MEDS slides 5.9% to $2.85
- Closed at $2.85, -5.94% vs the prior close of $3.03. Day range $2.80–$3.04, opened at $2.90.
- Volume was 672.50K shares, 0.1x its 50-day average of 8.16M — lighter than usual.
- Price is +23.7% vs its 50-day average ($2.30) and -58.9% vs its 200-day average ($6.94).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 96.1% below the 52-week high.
Oct 13, 2026 — MEDS dips 1.3% to $3.03
- Closed at $3.03, -1.30% vs the prior close of $3.07. Day range $2.94–$3.15, opened at $2.95.
- Volume was 867.30K shares, 0.1x its 50-day average of 8.15M — lighter than usual.
- Price is +31.2% vs its 50-day average ($2.31) and -56.9% vs its 200-day average ($7.03).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 95.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — MEDS jumps 3.7% to $3.07 on 2.7x normal volume
- Closed at $3.07, +3.72% vs the prior close of $2.96. Day range $3.00–$3.80, opened at $3.31.
- Volume was 21.21M shares, 2.7x its 50-day average of 7.72M — unusually heavy trading.
- Price is +32.6% vs its 50-day average ($2.31) and -56.9% vs its 200-day average ($7.12).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 95.8% below the 52-week high.
Oct 9, 2026 — MEDS slides 12.9% to $2.96
- Closed at $2.96, -12.94% vs the prior close of $3.40. Day range $2.95–$3.30, opened at $3.16.
- Volume was 482.20K shares, 0.1x its 50-day average of 7.71M — lighter than usual.
- Price is +28.0% vs its 50-day average ($2.31) and -59.0% vs its 200-day average ($7.21).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 95.9% below the 52-week high.
Oct 8, 2026 — MEDS jumps 18.1% to $3.40 on 1.9x normal volume
- Closed at $3.40, +18.06% vs the prior close of $2.88. Day range $2.88–$3.70, opened at $3.13.
- Volume was 14.06M shares, 1.9x its 50-day average of 7.43M — unusually heavy trading.
- Price is +46.7% vs its 50-day average ($2.32) and -53.5% vs its 200-day average ($7.32).
- 52-week range $0.82–$73.00; today's close sits at 4% of that range, 95.3% below the 52-week high.
Oct 7, 2026 — MEDS slides 6.2% to $2.88, 4 down days in a row
- Closed at $2.88, -6.19% vs the prior close of $3.07. Day range $2.84–$3.13, opened at $3.10.
- Volume was 357.60K shares, 0.0x its 50-day average of 7.43M — lighter than usual.
- Price is +24.7% vs its 50-day average ($2.31) and -61.2% vs its 200-day average ($7.42).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 96.1% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — MEDS slides 8.4% to $3.07, 3 down days in a row
- Closed at $3.07, -8.36% vs the prior close of $3.35. Day range $3.04–$3.36, opened at $3.20.
- Volume was 640.10K shares, 0.1x its 50-day average of 7.42M — lighter than usual.
- Price is +32.2% vs its 50-day average ($2.32) and -59.2% vs its 200-day average ($7.53).
- 52-week range $0.82–$73.00; today's close sits at 3% of that range, 95.8% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — MEDS slides 9.0% to $3.35
- Closed at $3.35, -8.97% vs the prior close of $3.68. Day range $3.35–$3.67, opened at $3.55.
- Volume was 659.00K shares, 0.1x its 50-day average of 7.40M — lighter than usual.
- Price is +44.2% vs its 50-day average ($2.32) and -56.1% vs its 200-day average ($7.64).
- 52-week range $0.82–$73.00; today's close sits at 4% of that range, 95.4% below the 52-week high.
Oct 2, 2026 — MEDS slides 9.4% to $3.68
- Closed at $3.68, -9.36% vs the prior close of $4.06. Day range $3.56–$3.94, opened at $3.86.
- Volume was 1.16M shares, 0.2x its 50-day average of 7.38M — lighter than usual.
- Price is +58.6% vs its 50-day average ($2.32) and -52.5% vs its 200-day average ($7.75).
- 52-week range $0.82–$73.00; today's close sits at 4% of that range, 95.0% below the 52-week high.
MEDS latest news & SEC filings
Every SEC filing by or about MEDS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 3.02 — Sold unregistered shares.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 9, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Oct 9, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 31, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 17, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.78M (prior year $7.79M) (-77.2% vs Jun 30, 2025)
- Net income: -$18.36M (prior year -$6.67M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$7.13 (prior year -$5.40) (loss widened vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 7, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade MEDS
- Last results release: Aug 18, 2026 (8-K Item 2.02). Previous ones: May 19, 2026, Nov 20, 2025, Aug 22, 2025. Based on that rhythm, the next report is likely around Nov 17, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 9.70% (largest 28.1%). That is a volatile stock.
- Liquidity: about 5.84M shares (≈$15.36M) trade per day on average.
- 52-week position: $2.63 vs a range of $0.82–$73.00 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on May 26, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 13, 2026; 8-K Sep 17, 2026.
- Share count: 3.06M shares outstanding (Aug 17, 2026), -96.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries.
MEDS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.80 | 2.86 | 2.62 | 2.63 | 286.40K |
| Oct 15, 2026 | 2.71 | 2.88 | 2.65 | 2.85 | 248.70K |
| Oct 14, 2026 | 2.90 | 3.04 | 2.80 | 2.85 | 672.50K |
| Oct 13, 2026 | 2.95 | 3.15 | 2.94 | 3.03 | 867.30K |
| Oct 12, 2026 | 3.31 | 3.80 | 3.00 | 3.07 | 21.21M |
| Oct 9, 2026 | 3.16 | 3.30 | 2.95 | 2.96 | 482.20K |
| Oct 8, 2026 | 3.13 | 3.70 | 2.88 | 3.40 | 14.06M |
| Oct 7, 2026 | 3.10 | 3.13 | 2.84 | 2.88 | 357.60K |
| Oct 6, 2026 | 3.20 | 3.36 | 3.04 | 3.07 | 640.10K |
| Oct 5, 2026 | 3.55 | 3.67 | 3.35 | 3.35 | 659.00K |
| Oct 2, 2026 | 3.86 | 3.94 | 3.56 | 3.68 | 1.16M |
| Oct 1, 2026 | 3.90 | 4.35 | 3.63 | 4.06 | 34.90M |
| Sep 30, 2026 | 3.48 | 3.48 | 3.17 | 3.17 | 548.80K |
| Sep 29, 2026 | 3.90 | 3.96 | 3.60 | 3.67 | 1.48M |
| Sep 28, 2026 | 3.97 | 4.65 | 3.44 | 3.81 | 33.44M |
| Sep 25, 2026 | 3.43 | 3.44 | 3.01 | 3.11 | 410.30K |
| Sep 24, 2026 | 3.65 | 3.77 | 3.44 | 3.50 | 317.60K |
| Sep 23, 2026 | 4.01 | 4.09 | 3.80 | 3.83 | 595.60K |
| Sep 22, 2026 | 4.10 | 5.38 | 3.91 | 4.28 | 2.42M |
| Sep 21, 2026 | 4.17 | 4.55 | 3.75 | 4.18 | 2.08M |
About DataMeds AI
DataMeds AI (MEDS) is listed on the Nasdaq and classified by the SEC under “Wholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in TAMPA, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2030763.
MEDS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Surendra K Ajjarapu | Director | Jun 25, 2026 |
| Howard A. Doss | Director | Oct 24, 2025 |
| Donald G. Fell | Director | Oct 21, 2025 |
| Gary L Herman | Director | Apr 10, 2026 |
| Steven Dale Lee | Director | Oct 14, 2025 |
| Prashant Patel | Chief Executive Officer | Jun 25, 2026 |
| Eric Michael Sherb | Director | Apr 9, 2026 |
| Marlene Velez | Director | Apr 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Prashant Patel | Chief Executive Officer | Jun 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MEDS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $23.34M | $-101.27M | -1.43 | $-10.86M |
| Dec 31, 2024 | $18.13M | $-6.86M | -0.15 | $-1.22M |
| Dec 31, 2023 | — | $-2.90M | -0.06 | $-349.14K |
Latest balance sheet: total assets $32.76M, total liabilities $52.26M, cash $2.46M (as of Jun 30, 2026).
MEDS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 18, 2026 | 8-K Item 2.02 (results) | $1.38 |
| May 19, 2026 | 8-K Item 2.02 (results) | $8.40 |
| Nov 20, 2025 | 8-K Item 2.02 (results) | $24.45 |
| Aug 22, 2025 | 8-K Item 2.02 (results) | $47.25 |
Related stocks · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Mckesson (MCK)Cardinal Health (CAH)Cencora (COR)Herbalife (HLF)Nu Skin Enterprises (NUS)Cosmos Health (COSM)HWH International (ESYN)Cellyan Biotechnology (HKPD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MEDS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.